A comparison of two methods of endoscopic dilation of acute subglottic stenosis using a ferret model.

Objectives/hypothesis: Balloon dilation is accepted as a first line treatment of acute subglottic stenosis, but its effects on the subglottic tissue remain largely unknown. We aimed to develop an animal model of acute subglottic stenosis using endoscopic techniques. Once developed, this model was used to compare the immediate effects of balloon dilation and endotracheal tube dilation on subglottic tissue.

Phase transitions of n-hexadecane in nanoencapsulated binary solutions of n-hexadecane and 1-octanol.

Binary solutions of n-hexadecane and 1-octanol were encapsulated within poly(tert-butyl methacrylate) nanocapsules and the phase transition behavior of the n-hexadecane studied. A sigmoidal correlation was found between the binary composition of the encapsulated oil and the oil formulation prior to encapsulation. At low 1-octanol fractions in the synthesis, almost no alcohol was encapsulated, but at high 1-octanol fractions, the capsules were enriched in alcohol.

Mononuclear nitrogen/sulfur-ligated cobalt(II) methoxide complexes: structural, EPR, paramagnetic 1H NMR, and electrochemical investigations.

The first examples of mononuclear nitrogen/sulfur-ligated Co(II) alkoxide complexes, species of relevance to a reactive intermediate observed for Co(II)-substituted liver alcohol dehydrogenase, have been isolated and characterized by multiple methods including X-ray crystallography, EPR, paramagnetic (1)H NMR, and cyclic voltammetry.

Mononuclear N3S(thioether)-ligated copper(II) methoxide complexes: synthesis, characterization, and hydrolytic reactivity.

Mononuclear copper(II) methoxide complexes supported by N(3)S(thioether) chelate ligands having two internal hydrogen bond donors have been prepared, comprehensively characterized, and evaluated for hydrolytic reactivity.

Synthesis and characterization of mononuclear zinc aryloxide complexes supported by nitrogen/sulfur ligands possessing an internal hydrogen bond donor.

Treatment of a dinuclear zinc hydroxide complex ([(bmnpaZn)(2)(mu-OH)(2)](ClO(4))(2) (1) or [(benpaZn)(2)(mu-OH)(2)](ClO(4))(2) (2)) with excess equivalents of an aryl alcohol derivative (p-HOC(6)H(4)X; X = NO(2), CHO, CN, COCH(3), Br, H, OCH(3)) yielded the nitrogen/sulfur-ligated zinc aryloxide complexes [(bmnpa)Zn(p-OC(6)H(4)NO(2))](ClO(4)) (3), [(benpa)Zn(p-OC(6)H(4)NO(2))](ClO(4)) (4), [(benpa)Zn(p-OC(6)H(4)CHO)](ClO(4)) (5), [(benpa)Zn(p-OC(6)H(4)CN)](ClO(4)) (6), [(benpa)Zn(p-OC(6)H(4)COCH(3))](ClO(4)) x 0.5H(2)O (7), [(benpa)Zn(p-OC(6)H(4)Br)](ClO(4)) (8), [(benpa)Zn(p-OC(6)H(5))](ClO(4)) (9), and [(benpa)Zn(p-OC(6)H(5)OCH(3))](ClO(4)) (10). The solid state structures of 2, 3, 5, and 6 have been determined by X-ray crystallography.